SEC Form 4 · accession 0001274644-16-000093
Ocera Therapeutics, Inc. · OCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Byrnes
Officer — CFO and Treasurer
Period of report
Jan 15, 2016
Accepted (ET)
Jan 19, 2016 · 8:14 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 15, 2016 | P | 3,500 | $2.07 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average price for the shares. The shares were purchased at prices ranging from $2.06 per share to $2.10 per share.
- F2The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.